Clinical

Global perceptions for the profession of #medical laboratory sciences

Posted on

Biomedical Laboratory Technologists or Scientists play a fundamental role in diagnosis and #disease management of patients. South Africa has the largest economy in Africa but is one of the most inequitable societies in the world, illustrated by the disparity between private and public sector healthcare funding. Eighty-four percent of South Africans cannot afford to contribute to private health care insurance and are thus reliant on the public health care systems which utilize the laboratory services provided by the National Health Laboratory Services (NHLS). The NHLS provides South Africans access to pathology services in both the private and state funded medical laboratories. The service provides a comprehensive range of laboratory tests across all medical laboratory science disciplines.

View more at https://www.scitechnol.com/archives-clinical-pathology.php

Mail your query at pathology@scitechnol.com

Advertisements

Reducing wasteful innovation

Posted on Updated on

Healthcare organisations are increasingly being asked to innovate in order to improve or maintain quality of care while reducing costs. This has, in turn, led to an explosion in Funding to support innovation and a multitude of innovations being introduced or tested. The focus has been on creating the environment to generate inno-vation and then implementing such innovations

View Journal update at https://www.scitechnol.com/global-health-journal.php

Mail us your queries or concerns at globalhealth@peerreviewedjournals.com

Follow us at https://twitter.com/globalh59904289

Febuxostat prevents gout flares in recent clinical trial

Posted on Updated on

The Drug febuxostat reduced gout flares in a double-blind, placebo-controlled study of 314 adults with early gout. Febuxostat treatment also reduced synovitis — or inflammation of the joint lining detected by MRI scanning — over a 2-year period compared with placebo. Febuxostat treats high urate in the blood of patients with gout. “Current clinical practice guidelines do not recommend routine use of urate-lowering therapy for people after the first gout flare. This study indicates that even for people who have had only 1 or 2 prior gout flares, urate-lowering therapy to reduce serum urate below 6mg/dL may have benefit in reducing future flares,” said Dr. Nicola Dalbeth, lead author of the study.

Read more articles of this subject at Orthopedics

Prototype UT equipment can detect rheumatoid arthritis

Posted on Updated on

According to a first clinical study published in the scientific journal Photoacoustics, the University of Twente and various European partners have designed a device that shows the difference between healthy fingers and arthritic fingers. The University of Twente and Ziekenhuis Groep Twente researchers responsible for the development of the compact device believe that it may in time help doctors to objectively diagnose the degree of inflammation in joints.

Read more articles of this subject at Orthopedics

SciTechnol

Posted on

SciTechnol is an online publisher that enjoys global presence with International Journals on Clinical, Medical, Environmental, Pharmaceutical, Neurosciences, Environmental Science, and Business Management. SciTechnol offers a meaningful platform to the global scientific community to discuss and share knowledge while disseminating research findings globally.

The mission of SciTechnol is to take the high quality research work close to a wide range of academic and scientific communities.

SciTechnol offers a prompt and efficient review process that enhances the quality of the publication. The ultimate goal of SciTechnol is to aid the scientific community with periodicals focusing on

  • Scientific discoveries
  • Providing data to further research and documentation.

We strive to offer world class service that enables our authors to increase their research impact and reputation.

Our Features

  • 104 Hybrid Access online Journals
  • Online Submission System
  • Quality review process through Editorial Manager
  • 1500 Editorial team
  • 2 Million readers
  • Social Networking -More than 50,000 Facebook Likes
  • Fast Publication Process
  • Audio Conversion Enhanced Feature
  • Digital Articles

Evaluation of human epidermal growth factor receptor (HER-2/neu) in #gastric #adenocarcinoma: A study from South Asia region

Posted on

Background & Aim: Gastric cancer is the third leading cause of cancer mortality worldwide. Human epidermal growth factor (HER- 2/neu) has shown strong therapeutic implication in breast cancer. Expression of HER-2/neu in gastric cancer has been reported from across the world, it is still unknown from South Asia region. The aim of this study is to evaluate HER-2/neu expression in gastric adenocarcinomas and to correlate with various clinicopathological variables. Patients & Method: A total of 95 consecutive patients undergoing endoscopic biopsy or gastrectomy were recruited in this study after institutional ethical approval. Clinicopathological parameters of all patients were recorded and hematoxylin and eosin (H&E) staining was performed.

View more at https://www.scitechnol.com/archives-clinical-pathology.php

Mail your query at pathology@scitechnol.com

Running with prosthetic lower-limbs: Advantage or disadvantage?

Posted on Updated on

Researchers at Bournemouth University have been looking at the impact of lower-limb prosthetics on competitive running, specifically looking at whether athletes with prosthesis are at an unfair advantage when running against athletes without prosthetics.

View related article at Orthopedics.